Top 50 Medical Device VC (Venture Capital) Funds in Oceania in January 2025
A list of 50 VC (Venture Capital) funds that invest in Medical device startups based in Oceania. We rank investors based on the number of investments they made in Medical device companies from Oceania. We update this investor list every month.Top 50 Medical Device VC (Venture Capital) Funds in Oceania in January 2025
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Australia, United States, Hong Kong
Portfolio highlights
- GALY — Saving Our Planet by Transitioning the World to Cellular Agriculture
- Ohmie Go — EV charging solutions, shared electric vehicles, shared e-bikes & e-scooters delivered to residents as a premium managed service and amenity - An intelligent way to get EV ready with one seamless experience.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
- Biotechnology, Information Technology, Manufacturing
- Angel, Seed, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Aurtra — Aurtra delivers highly cost-effective asset management solutions for power distribution transformers through online condition monitoring and state of the art analysis.They provide the insight to significantly reduce capital costs through maximum asset utilisation. Aurtra is an Australian company, based in sunny Brisbane, Australia. Aurtra wasincorporated in 2016 and has built its IP upon a foundation of world’s best practice technology from The University of Queensland, following a decade of transformer research between academia and industry. Aurtra’s three founders, all with success commercialising hardware and software technology, recognised the potential of the technology and its beneficial impact for asset management in the power distribution industry.
- Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
- Seitec — Seitec is a security company that manufactures seismic security applications and instruments for civilian and military markets.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- New Zealand, United States, United Kingdom
Portfolio highlights
- Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
- Watchful — Watchful operates as an AI security company.
- Crimson Education — Crimson Education is the world's leading higher educational consultancy helping students around the world gain admission into leading US and UK universities by up to 400%!
Investing in great people solving hard problems to create a better future.
Show more
Investment focus
- Medical Device, Medical, Information Technology
- Seed, Series A
- New Zealand, Australia
Portfolio highlights
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Conry Tech — Conry Tech is a climate tech company, reinventing air-conditioning to decarbonise and improve comfort, founded by renowned HVAC industry revolutionising experts.
- Green Gravity — Green Gravity is an electric power generation company that enables renewable energy transition using energy storage technology.
Auckland University's commercialisation arm
Show more
Investment focus
- Medical Device, SaaS, Audio
- Seed, Pre-Seed
- New Zealand
Portfolio highlights
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
- Software, Health Care, SaaS
- Seed, Angel, Series A
- Australia, United States
Portfolio highlights
- Okkular — Okkular is an AI based fashion tech startup.
- Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more
Investment focus
- Manufacturing, Health Care, Software
- Funding Round, Series A, Seed
- Australia, United States, Philippines
Portfolio highlights
- Umps Health — Umps offers a 24/7 personal alarm that helps you live independently with peace of mind. Easy to use, always connected.
- Conflux Technology — Conflux Technology is a new generation of heat exchangers made by metal additive manufacturing (3D printing).
- Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- New Zealand, United States
Portfolio highlights
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Diraq — Diraq uses spins in silicon quantum dots as qubits. Diraq's qubits are compatible with existing CMOS processes and can fit billions of qubits on a single chip. To transform our world, quantum computers need billions of qubits and Diraq has the IP, the team and the plan to get there.
- Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more
Investment focus
- Software, SaaS, Medical Device
- Seed, Series A, Funding Round
- New Zealand, United States, China
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Investing in innovation for a healthy childhood
Investing in innovation for a healthy childhood
About Cure Kids Ventures
Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to
Show more
Investment focus
- Medical Device, SaaS, Medical
- Seed, Pre-Seed, Series A
- New Zealand
Portfolio highlights
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
- Health Care, Biotechnology, Therapeutics
- Seed, Series A, Series B
- United Kingdom, United States, Australia
Portfolio highlights
- Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
- Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
- MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more
Investment focus
- Biotechnology, Robotics, Nanotechnology
- Seed
- New Zealand, United States
Portfolio highlights
- Ligar — Providing molecular filtration solutions to companies in the food, beverage, health, therapeutics, flavour and aroma industries. Our unique MIP and Polymer technology enables companies to improve their products and operational processes by extracting, reducing or concentrating flavours or compounds.
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- PowerON — Dielectric Elastomers for Soft Robotics
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series B, Series C, Funding Round
- United States, India, Austria
Portfolio highlights
- Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Super-seeded by new entry: Flying Kiwi Angels
Show more
Investment focus
- SaaS, 3D Technology, Medical Device
- Seed
- New Zealand
Portfolio highlights
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Punakaiki Fund Limited makes long-term investments into high-growth, revenue-generating New Zealand companies. The company holds 20 investments, $32.3 million in assets, and is raising money in December 2017 for further investment.
Show more
Investment focus
- Software, SaaS, Mobile Apps
- Seed, Series A, Series B
- New Zealand, United States
Portfolio highlights
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
- Whip Around — Whip Around develops and builds solutions that tackle the paper-based compliance burden for a wide variety of transport companies in the United States and around the world. Effortlessly manage your fleet inspections, compliance, preventative maintenance, work orders, reporting & more! Create powerful checklists for your assets. Have yourdrivers conduct inspections anywhere, anytime via the Whip Around mobile app. Get alerts sent to you immediately, view the reports from the management dashboard and manage faults with ease. Come see why more than 85,000 users globally love Whip Around. Trial Whip Around free for 7 days!
- projectworks — Project Works is a cloud based workforce management platform designed to help professional & creative services businesses better manage their organisations in the areas of project management, project financials, and people management. Our mission is to provide a platform that enables world class services businesses to get the most out of theirexisting workforce, and enable them to grow.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro Shatters the Wi-Fi HaLow Range Record... AgainSets New Benchmark in Connectivity with Record 16 km Wi-Fi HaLow Range Watch Now 10X
Flying Kiwi Angels ? Helping Kiwi Startups
Show more
Investment focus
- Software, Information Technology, Apps
- Seed, Angel, Pre-Seed
- New Zealand
Portfolio highlights
- FileInvite — The simplest, most secure, document collection platform for professionals. Request files, forms, data and e-signatures all through a secure client portal.
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
- Kara Technologies — Content accessibility using a signing avatar. Accessible solutions are at the core of all that we do here at Kara. One of our main goals is finding smarter ways of using technology that will help build a better future for everyone, in all areas of life.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
- Software, Financial Services, FinTech
- Funding Round, Series B, Convertible Note
- Australia, United States, United Kingdom
Portfolio highlights
- Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
- Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
- Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Pre-Seed
- New Zealand, United States, China
Portfolio highlights
- Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
- Layer3 — Layer3 is a crypto platform that provides tools for decentralized autonomous organizations (DAOs).
- Type One Energy — At Type One Energy, we are mission-driven to provide sustainable, affordable fusion power to the world over the coming decade.
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Series A, Funding Round
- New Zealand, United States
Portfolio highlights
- Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
- Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series B, Series A, Series C
- United States, Australia, United Kingdom
Portfolio highlights
- Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
- Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
- Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech
Show more
Investment focus
- Software, Health Care, Machine Learning
- Seed, Funding Round, Series A
- United States, Colombia, India
Portfolio highlights
- Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
- MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
- Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Topcon Healthcare empowers providers with advanced imaging, diagnostic solutions and intelligent data technology, offering a more fully integrated approach to diagnosis and treatment in eyecare.
Show more
Investment focus
- Health Care, Medical Device, Health Diagnostics
- Series A
- New Zealand
Portfolio highlights
- RetiSpec — RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of the eye.
- Toku Eyes — Instant Healthcare Diagnostics. Toku Eyes developed a multi-modal artificial intelligence platform for instant healthcare diagnostics...
- Retinai — RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietarytechnology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Switzerland, Canada
Portfolio highlights
- 858 Therapeutics — 858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology. The company was founded in 2019 and is headquartered in San Diego, California, USA.
- Antag Therapeutics — Antag Therapeutics operator of a biotechnology company intended to develop metabolic and anti-obesity therapeutic drugs.The company specializes in the development of peptide-based GIP receptor antagonist in order to monitor dietary-related metabolic diseases through the infusion, enabling the healthcare industry to decrease blood flow and lipiduptake in adipose tissue in an efficient manner.
- Pep2Tango Therapeutics — Pep2Tango Therapeutics is a biotechnology company that offers superior unimolecular multi-receptor drugs for obesity and related disorders.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
- Software, Enterprise Software, Information Technology
- Series A, Series B, Funding Round
- United States, Australia, Philippines
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,257,377 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Software
- Series A, Series B, Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
- Medal — Gamers live here. Medal is the best way to record, clip, edit, and share your gaming clips and videos. Clip, Edit, Share, and Relive your gaming moments.
- ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Funding Round, Pre-Seed
- United States, India, Canada
Portfolio highlights
- VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
- UniPay — UniPay is an eCommerce platform for infrastructure and industry-lacking regions that offers 5 products that enable trust, promote transparency, and enforce accountability.
- Emission Sentri — Drive emission management and reduction with insights
Booster is an investment manager, superannuation and default KiwiSaver scheme provider.
We offer ethical, New Zealand and specialist investment options.
Show more
Investment focus
- Medical Device
- Seed
- New Zealand
Portfolio highlights
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures
Show more
Investment focus
- Solar, FinTech, Big Data
- Seed, Series A, Funding Round
- United States, France, New Zealand
Portfolio highlights
- Granular — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
- Granular Energy — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
- Liquid Instruments — Redefining the way scientists, engineers, students, and professionals experience test and measurement with Moku software-reconfigurable hardware platforms
At UniServices, we partner with the University of Auckland to transform ideas into real-world solutions that impact globally.
Show more
Investment focus
- Medical, Marketing, Health Care
- Seed, Pre-Seed
- New Zealand
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Quayside Holdings is the investment arm of the Bay of Plenty Regional Council which responsibly manages the listed assets, property, equities and private equity investments.
Show more
Investment focus
- Sensor, FinTech, Hardware
- Seed, Series B
- New Zealand
Portfolio highlights
- TradeWindow — TradeWindow provides the tools and support for exporters, importers, freight forwarders, and customs brokers to begin the journey to digital transformation.
- WNT Ventures — New Zealand's Venture Capital Deep Tech Investor. Investing in Deeptech founders from Aotearoa to build local companies and help them go global
The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.
Show more
Investment focus
- Sensor, Medical, Wearables
- Funding Round
- Australia
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
Your guide to finding and using government services.
Show more
Investment focus
- Software, Biotechnology, SaaS
- Seed, Series A, Angel
- New Zealand, United States, Japan
Portfolio highlights
- Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
- Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
- Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Seed, Pre-Seed, Series A
- Australia, United States, India
Portfolio highlights
- Anility — Embed financial health insights within your application using our world leading API service
- Ahura AI — Ahura AI, an EdTech startup using artificial intelligence to create personalized learning tools that replicate a 1-to-1 learning experience
- Ensuredit — ENSUREDIT enables and empowers end customers and Insurance Intermediaries with AI-based product platforms for transformational customer experience.
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Series A, Series B
- Australia, United States, New Zealand
Portfolio highlights
- Build Club — Build Club is a home for big dreams and top builders where the world's top AI builders gather. The company is a team of a global network of engineers, researchers, and founders building at the frontier of AI.
- Watchful — Watchful operates as an AI security company.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
We're an early-stage venture capital firm investing in technology companies at the Seed and Series A stage.
Show more
Investment focus
- Software, Developer Tools, Apps
- Seed, Series A, Funding Round
- Australia, Canada, United Kingdom
Portfolio highlights
- Amaka — Accounting integrations and automation solutions for SMBs. Sync data from POS and e-commerce business apps to Xero, QuickBooks, MYOB and more.
- Riparide — Riparide helps you plan and book your next escape through our Storyteller travel guides. These guides, called Riparide Stories, come packed with unique stays, local adventures and social vibes....
- Lasertrade — Lasertrade is an online marketplace that offers a wide range of medical devices and equipment for the healthcare sector.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Debt Financing
- United Kingdom, Australia, United States
Portfolio highlights
- Amped PCR — Explore Amped PCR's advanced DNA amplification solutions for precise molecular diagnostics. Trusted by food safety authorities and biotech companies. Learn more
- Coffi Lab — Dog friendly independent coffee shops, inspired by our love of coffee & labs. In Monmouth, Marlborough & Abergavenny. Proud Supporter of Guide Dogs UK.
- Stable Resources — We are Stable. We pioneer new ways for teams to collaborate and innovate with technology being the enabler.
LCO Capital offer value-add financial and intellectual capital to underperforming business lines, using an LCO℠ business model.
Show more
Investment focus
- Health Care, Manufacturing, Medical Device
- Funding Round
- New Zealand
Portfolio highlights
- Chitogel — Chitogel is a medical device company that offers edge wound healing gel for use in endoscopic sinus surgery.
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A, Debt Financing, Funding Round
- Australia, United States, Israel
Portfolio highlights
- Hometime — At Hometime, we provide Airbnb property management solutions for homeowners and rental management business owners that help them scale and earn more.
- StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
- Employment Hero — Employment Hero is Australia's top cloud-based HR, payroll and benefits platform for employers & employees. FREE trial for...
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more
Investment focus
- Advice, Hospital, Software
- Series A, Funding Round
- Australia
Portfolio highlights
- Vantari VR — Virtual Reality for Healthcare
- DASH Technology — DASH Technology provides financial services. They provide software, platform, and even wealth management space services. They provide advisers and broader wealth services. They provide inquiries through email, phone calls, and online applications.
We invest in Western Australian Innovators with bold ideas and global ambitions. We invest at Seed to Series-A in Western Australian companies.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Seed, Series A
- Australia
Portfolio highlights
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
- VitalTrace — VitalTrace is a medical device company helps mothers and children during labour and delivery by innovating new monitoring devices.
Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B
- Australia
Portfolio highlights
- Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.
Show more
Investment focus
- Health Care, Medical Device
- Series A
- Australia
Portfolio highlights
- Baymatob — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more
Investment focus
- Health Care, Biotechnology, SaaS
- Funding Round, Series A, Series B
- Australia
Portfolio highlights
- Lumary — Simplify Your Care Management Optimise Your Organisation Create Better Wellbeing
- BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Skip Capital is a private investment fund investing in technology and infrastructure
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Series A, Seed, Series B
- Australia, United States, Canada
Portfolio highlights
- Askable — Askable offers a comprehensive research platform that facilitates access to certified researchers and verified participants globally. The platform streamlines the research process from recruitment to analysis, enabling teams to gather insights efficiently.
- Visibuild — Visibuild is a construction software web & mobile platform providing real-time insights, workflows, defect tracking, ITPs inspections.
- GROWL — Discover GROWL: the smart boxing bag blending cardio, strength, and gaming. Experience an immersive home boxing coach and step up your performance.
Bridgewest Group is a closely held investment company with global assets in the biotech, wireless communications, infrastructure for "internet of things," semiconductor, real estate, and financial services industries.
Show more
Investment focus
- Mobile, Hardware, Internet
- Seed, Funding Round
- New Zealand, United States
Portfolio highlights
UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed
- Australia
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
Investors by industry
Consumer
Hardware
Climate
Proptech
Gaming
Google
Marketplace
Biotech
Impact
Community
Energy
FinTech
Artificial intelligence
Health Care
EdTech
Sustainability
Venture Capital
Real Estate
Retail
Clean Energy
Food and Beverage
B2B
Video Games
Web3
Photography
Education
Big Data
Finance
Financial Services
Payments
Beauty
Publishing
Infrastructure
Organic Food
Social Network
Social Media
Digital Media
Art
Medical
Android
Franchise
Mobile
Local
Music
Legal
Enterprise Software
eSports
Construction
Sports
Internet
Wellness
Email
Manufacturing
Recruiting
Mobile Advertising
Travel
Hospitality
Cannabis
Fitness
Biotechnology
Platforms
Wine And Spirits
Automotive
Social
Medical Device
Crowdfunding
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
Canada
United States
New Zealand
South Korea
Ireland
India
Australia
Africa
Sri Lanka
Europe
Middle East
China
Qatar
Vietnam
Armenia
Oceania
Brazil
Indonesia
Asia
South Africa
Spain
Saudi Arabia
Japan
Singapore
LATAM
Estonia
Bermuda
Gibraltar
Liechtenstein
Belarus
Croatia
Ethiopia
Belize
Egypt
Georgia
France
Denmark
Costa Rica
Greece
Mauritius
Czech Republic
Hungary
Ecuador
Faroe Islands
Chile
Ghana
Finland
Bahrain
Algeria
Hong Kong
Belgium
Lithuania
Bulgaria
Barbados
Senegal
Uruguay
Puerto Rico
Sweden
El Salvador
Sierra Leone
Uganda
Slovenia
Taiwan
Togo
Seychelles
Zambia
Venezuela
Tajikistan
Zimbabwe
Russian Federation
Turkey
Tunisia
Italy
Uzbekistan
Thailand
Rwanda
San Marino
Serbia
Tanzania
Ukraine
Portugal
Poland
Philippines
Dominican Republic
Mali
Bahamas
Liberia
Iceland
Namibia
Nigeria
Azerbaijan
Iraq
Jersey
Malaysia
United Arab Emirates
Jamaica
Honduras
Israel
Isle of Man
Bolivia
Luxembourg
Malta
Albania
Pakistan
Lebanon
Norway
Myanmar
Morocco
Jordan
Bangladesh
Argentina
Romania
Grenada
Peru
Nicaragua
Mexico
Panama
Kuwait
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Marshall Islands
Colombia
Guatemala
VC (Venture Capital) Funds in Oceania by industry
Restaurants
Crowdfunding
Venture Capital
Retail
Real Estate
Financial Services
Cryptocurrency
Finance
Payments
Food and Beverage
Video Games
Medical
Wine And Spirits
Wellness
Medical Device
Biotech
Internet
Email
Social Network
Art
Manufacturing
Digital Media
Music
Android
Mobile
Legal
Construction
Software
eSports
Enterprise Software
Fitness
Hospitality
Automotive
CleanTech
Travel
Platforms
Biotechnology
FinTech
Cannabis
Enterprise
Consumer
Health Care
EdTech
Energy
Climate
Sustainability
Proptech
Marketplace
SaaS
Community
Hardware
Social
Beauty
Fashion
Web3
B2B
Life Science
Big Data
Education
Clean Energy
Infrastructure
Oil and Gas
Renewable Energy
Social Media
Non Profit
Social Impact
Mobile Apps
Publishing
InsurTech
Sporting Goods
Blockchain
Sports
Recruiting
Transportation
Impact
Agriculture (agtech)
Gaming
Media (entertainment)
Artificial intelligence